Ameriprise Financial »

Rapport Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $456k 15k 31.29
2025-12-31 $449k 15k 30.34
2025-09-30 $3.7M 125k 29.70